摘要
目的:分析临床药师参与1例重型新冠肺炎(COVID-19)患者的药物治疗实践,探究临床药师参与重型COVID-19患者的抗感染治疗和开展药学监护的方法。方法:临床药师应用药学专业知识和最新的临床研究证据,参与和协助临床调整抗感染药物治疗方案。结果:临床药师积极参与重型COVID-19患者治疗过程的药学监护,及时发现患者的药物治疗问题,提出合理化建议。结论:临床药师参与重型COVID-19患者的抗感染药物治疗方案的制订,找到融入临床治疗团队的切入点,将理论知识和临床实践相结合,可优化药物治疗方案,既可提高临床药物治疗水平,又能提高患者用药的安全性、有效性。
Objective:To analyze the method of clinical pharmacists taking part in the medication of patient with severe COVID-19 and conducting pharmaceutical care,through the practice of drug treatment in Patient with severe COVID-19.Methods:The clinical pharmacists used the professional knowledge of pharmacy and the latest clinical research evidence to participate into the pharmaceutical care in one Patient with severe COVID-19,assisting the clinic to adjust the treatment regimen.Results:Clinical pharmacist actively participates in the pharmacy care of patient with severe COVID-19,timely detects problems of drug use and can promote rational drug use in the clinic to achieve obvious results.Conclusion:Clinical pharmacist participated in the formulation of the drug treatment plan in the patient with severe COVID-19 and found an entry point into the clinical treatment team.Combining the theoretical knowledge and clinical practice can not only optimize the medication regimen and raise the level of clinical drug treatment,but also improve medication safety and effectiveness.
作者
宋晓兵
王艳
吴庆荣
刘建平
SONG Xiao-bing;WANG Yan;WU Qing-rong;LIU Jian-ping(The Ganzhou No.5 People's Hospital Affiliated to Gannan Medical College,Ganzhou Jiangxi 341000,China)
出处
《抗感染药学》
2020年第8期1209-1212,共4页
Anti-infection Pharmacy
基金
赣州市指导性科技计划(编号GZ2017ZSF286)。
关键词
临床药师
重型新冠肺炎
抗感染治疗
药学监护
clinical pharmacist
severe COVID-19
anti-infection medication
pharmaceutical care
